IPCALAB Reports Robust Q2 2024 Results with Strong Sales Growth and Stable Profit Margins
IPCALAB, a major Indian pharmaceutical company, has announced its financial results for the second quarter of the 2024 fiscal year, ending September 2024. The results reveal substantial year-over-year growth in …